During the last session, Imunon Inc (NASDAQ:IMNN)’s traded shares were 23.87 million, with the beta value of the company hitting 1.69. At the end of the trading day, the stock’s price was $1.99, reflecting an intraday gain of 30.92% or $0.47. The 52-week high for the IMNN share is $3.65, that puts it down -83.42 from that peak though still a striking 81.41% gain since the share price plummeted to a 52-week low of $0.37. The company’s market capitalization is $34.90M, and the average intraday trading volume over the past 10 days was 58.51 million shares, and the average trade volume was 9.28 million shares over the past three months.
Imunon Inc (IMNN) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.50. IMNN has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.35.
Imunon Inc (NASDAQ:IMNN) trade information
Imunon Inc (IMNN) registered a 30.92% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 30.92% in intraday trading to $1.99, hitting a weekly high. The stock’s 5-day price performance is 398.50%, and it has moved by 125.75% in 30 days. Based on these gigs, the overall price performance for the year is 31.79%. The short interest in Imunon Inc (NASDAQ:IMNN) is 1.15 million shares and it means that shorts have 4.83 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 32.54%. While earnings are projected to return 28.15% in 2025, the next five years will return 28.83% per annum.
IMNN Dividends
Imunon Inc is due to release its next quarterly earnings on 2025-May-11. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Imunon Inc (NASDAQ:IMNN)’s Major holders
Imunon Inc insiders own 1.52% of total outstanding shares while institutional holders control 2.35%, with the float percentage being 2.38%. RENAISSANCE TECHNOLOGIES LLC is the largest shareholder of the company, while 21.0 institutions own stock in it. As of 2024-06-30, the company held over 0.11 million shares (or 1.184% of all shares), a total value of $0.13 million in shares.
The next largest institutional holding, with 74653.0 shares, is of GEODE CAPITAL MANAGEMENT, LLC’s that is approximately 0.7941% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $86627.0.
Also, the Mutual Funds coming in first place with the largest holdings of Imunon Inc (IMNN) shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund. Data provided on Mar 31, 2025 indicates that Fidelity Concord Street Trust-Fidelity Extended Market Index Fund owns about 80.38 shares. This amounts to just over 0.46 percent of the company’s overall shares, with a $0.16 million market value. The same data shows that the other fund manager holds slightly less at 48.81, or about 0.28% of the stock, which is worth about $97123.0.
